Phase 2 Hidradenitis Suppurativa (HS) Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Sinocelltech Ltd.60 enrolled1 locationNCT07244510
Recruiting
Phase 2
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Incyte Corporation40 enrolled27 locationsNCT07213973
Recruiting
Phase 2Phase 3
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Bluefin Biomedicine, Inc.210 enrolled33 locationsNCT07287644
Recruiting
Phase 2
A Study With CIT-013 in HS Patients
Hidradenitis Suppurativa (HS)
Citryll BV96 enrolled24 locationsNCT06993233
Recruiting
Phase 2
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Hidradenitis Suppurativa (HS)
Zura Bio Inc225 enrolled56 locationsNCT06993610
Recruiting
Phase 2
The Safety and Efficacy of Roflumilast Foam in HS
Hidradenitis Suppurativa (HS)
Beth Israel Deaconess Medical Center20 enrolled1 locationNCT07263230
Recruiting
Phase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Navigator Medicines, Inc.150 enrolled10 locationsNCT07384975